Deskripsi
Co-morbidity risk landscape for chronic PPI users includes associations with kidney disease, bone fractures, and gastrointestinal infections alongside the proposed dementia connection.
Figure 4
DiagramSource Paper
Proton Pump Inhibitors and Cognitive Health: Review on Unraveling the Dementia Connection and Co-morbid Risks.Cite This Figure
![Figure 4: Co-morbidity risk landscape for chronic PPI users includes associations with kidney disease, bone fractures, and gastrointestinal infections alongside the proposed dementia connection.]() > Source: Zuber Khan et al. "Proton Pump Inhibitors and Cognitive Health: Review on Unraveling the Dementia C." *Current Alzheimer research*, 2024. PMID: [38424433](https://pubmed.ncbi.nlm.nih.gov/38424433/)
<figure> <img src="" alt="Co-morbidity risk landscape for chronic PPI users includes associations with kidney disease, bone fractures, and gastrointestinal infections alongside the proposed dementia connection." /> <figcaption>Figure 4. Co-morbidity risk landscape for chronic PPI users includes associations with kidney disease, bone fractures, and gastrointestinal infections alongside the proposed dementia connection.<br> Source: Zuber Khan et al. "Proton Pump Inhibitors and Cognitive Health: Review on Unraveling the Dementia C." <em>Current Alzheimer research</em>, 2024. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/38424433/">38424433</a></figcaption> </figure>